Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Research and Markets: Japan Hyperbaric Oxygen Chambers Market Outlook to 2020: Key Players Covered Include Sechrist Industries Inc and Time World

Business Wire December 17, 2014

Research and Markets: India Digital Wound Measurement Devices Market Outlook to 2020: Key Players Covered Include Aranz Medical Limited

Business Wire December 17, 2014

SAGE Therapeutics Added to NASDAQ Biotechnology Index

GlobeNewswire December 17, 2014

Making Single-Cell Biology Work

Business Wire December 17, 2014

Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment

Marketwired December 17, 2014

Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials

PR Newswire December 17, 2014

Sean Parker Pledges $24 Million to Launch Allergy Research Center at Stanford

Business Wire December 17, 2014

Oncodesign has entered into a services agreement with Eisai to develop a new personalized medicine program in earlier line metastatic breast cancer treatment

Business Wire December 17, 2014

Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients

ACN Newswire December 16, 2014

INGDAN.com Cooperates with WeChat to Hold First WeChat IoT Innovation Contest

PR Newswire December 16, 2014

FDA Approves INTERCEPT Blood System for Plasma

Business Wire December 16, 2014

Ipsen's Somatuline® Depot® is the First Therapy Approved by the FDA in the United States for the Treatment of Patients with Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Business Wire December 16, 2014

Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Business Wire December 16, 2014

Auspex Announces Positive Topline Results From Registration Trial of SD-809 for Chorea Associated With Huntington's Disease

GlobeNewswire December 16, 2014

Alder BioPharmaceuticals Announces Addition to NASDAQ Biotechnology Index

GlobeNewswire December 16, 2014

Envita Publishes Important Chronic Lyme Disease Treatment Study

Marketwired December 16, 2014

Parent Project Muscular Dystrophy Names Massachusetts General Hospital a Certified Duchenne Care Center

PR Newswire December 16, 2014

Research and Markets: Global Oncology Market - Trends, Forecast and Pipeline Analysis 2014-2020 - Market is Poised to Grow to $109 Billion by 2020

Business Wire December 16, 2014

Research reveals domestication's effects on horse genes

UPI December 16, 2014

AIM Applauds AARP's Support of Closing Physician Self-Referral Loophole

Marketwired December 16, 2014